Evidence map›Paper›PMID 34829640›Full record

ArticleAntioxidants (Basel, Switzerland)2021

MnTnHex-2-PyP

Sung-Won Shin, Changhoon Choi, Hakyoung Kim, Yeeun Kim, Sohee Park, Shin-Yeong Kim, Ines Batinic-Haberle, Won Park

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. MnTnHex-2-PyPAntioxidants (Basel, Switzerland) · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sung-Won ShinDepartment of Radiation Oncology, Samsung Medical Center, Seoul 135710, Korea.
Changhoon ChoiDepartment of Radiation Oncology, Samsung Medical Center, Seoul 135710, Korea.ORCID 0000-0002-2847-1168
Hakyoung KimDepartment of Radiation Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul 02841, Korea.
Yeeun KimDepartment of Radiation Oncology, Samsung Medical Center, Seoul 135710, Korea.
Sohee ParkDepartment of Radiation Oncology, Samsung Medical Center, Seoul 135710, Korea.
Shin-Yeong KimDepartment of Radiation Oncology, Samsung Medical Center, Seoul 135710, Korea.
Ines Batinic-HaberleDepartment of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA.
Won ParkDepartment of Radiation Oncology, Samsung Medical Center, Seoul 135710, Korea.
Samsung Medical Center · KRDuke University · USKorea University Medical Center · KR

Funding

National Research Foundation of Korea NRF-2015R1D1A1A01060565National Research Foundation of Korea NRF-2019R1A2C2002304
6 · The paper itself

Abstract

Tumor migration and invasion induced by the epithelial-to-mesenchymal transition (EMT) are prerequisites for metastasis. Here, we investigated the inhibitory effect of a mimic of superoxide dismutase (SOD), cationic Mn(III)

Indexed as

adjuvant therapyEMTmanganese porphyrinmetastasisMnTnHex-2-PyP5+NRF2radiation therapySOD mimics

Identifiers

PMID34829640
PMCPMC8615021
OpenAlexW3212674341

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.